In the news / Cancer

NEWS
Researchers say using nanotechnology to deliver chemotherapy, could be a more effective way to fight aggressive tumors. Nanotechnology targets chemotherapy directly and selectively to cancerous cells.
 
NEWS
Dr. Melissa Herbst-Kralovetz discusses how bacteria influence female reproductive health.
 
NEWS

Nearly one quarter of the global disease burden is attributed to the elderly - a group expected to more than double by 2050. 

 
NEWS
Dr. Brittany Uhlorn discusses her career journey from scientist to science communicator.
 
NEWS
Cholangiocarcinoma is a rare, aggressive cancer affecting the bile ducts both in and outside of the liver. Experts estimate that 8000 people in the United States are diagnosed with this cancer each year, although the actual number is likely to be higher because it can be hard to diagnose and may be misclassified as other types of cancer.
 
NEWS
As a basic scientist and clinician, Dr. Juanita Merchant brings unique perspective to the her new role. as interim Associate Director For Basic Sciences at the UAZ Cancer Center, and hopes to cultivate bench-to-bedside translation at UArizona.
 
NEWS
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
 
NEWS
Dr. Jianqin Lu leads a research team which created the first nanotherapeutic platform of its kind, using a nanotechnology delivery method to make them more effective against aggressive tumors. The researchers note that their nanotechnology platform can be used to deliver a range of cancer therapeutics.
 
NEWS
The University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
 
NEWS
The Global Health Equity Scholars (GHES) fellowship program, a year-long research training program funded NIH Fogarty International Center, sends a new cohort of students to conduct research in low-and-middle-income countries around the world every year. This year, six fellows working with faculty mentors at UAZ MEZCOPH will pursue global health research around the world as part of this year’s program.
 
NEWS
Dr. Monica Yellowhair unites her cancer expertise with a love for education and her community to strive for health equity and a cancer-free Arizona. She applied for funding to study the genotoxic effects of uranium, a project that was one of the first selected for the Partnership for Native American Cancer Prevention.
 
NEWS
Dr. Monica Yellowhair unites her cancer expertise with a love for education and her community to strive for health equity and a cancer-free Arizona. She applied for funding to study the genotoxic effects of uranium, a project that was one of the first selected for the Partnership for Native American Cancer Prevention (NACP), a collaboration between NAU and the Cancer Center.
 
NEWS
Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions. In the last fiscal year alone UArizona received 274 invention disclosures and launched 17 startups.
 
NEWS
Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions.
 
NEWS
Biomedical engineering student Sebastian (Sebo) Diaz is among 55 students from 42 colleges and universities who have been selected as 2021 Udall Scholars, on the basis of commitment to careers in the environment, Tribal public policy, or Native health care; leadership potential; record of public service; and academic achievement.
 
NEWS
Some people who develop skin cancer don't have pale skin or red hair. The University of Arizona Skin Cancer Institute's Dr. Clara Curiel is identifying specific biomarkers that can identify those who don't typically fall within high-risk groups.
 
NEWS
In cases of breast cancer, bone metastasis – when cancer cells spread to new sites in the bone – causes the most breast cancer-related harm and is often incurable in advanced disease.
 
NEWS
UArizona College of Medicine – Tucson admitted its first class to the new 7-year medical degree early-admission Accelerated Pathway to Medical Education (APME) Program. Acceptance guarantees entry to the UArizona Honors College, and after three years, admission to UArizona COM-T.